ABPI response to Oxford/AstraZeneca vaccine approval
30 December 2020
Posted in News
by Press Office
The Government has today accepted the recommendation from the Medicines and Healthcare products Regulatory Agency (MHRA) to authorise Oxford University/AstraZeneca’s Covid-19 vaccine for use.
It’s great news that today we have another vaccine approved by the MHRA to help fight COVID-19. The world needs multiple vaccines to bring an end to the pandemic. In what has been a difficult year, it’s fantastic to see another scientific collaboration coming to fruition. Richard Torbett, Chief Executive, ABPI
In response to the news, ABPI Chief Executive Richard Torbett said:
“It’s great news that today we have another vaccine approved by the MHRA to help fight COVID-19.
“The world needs multiple vaccines to bring an end to the pandemic. In what has been a difficult year, it’s fantastic to see another scientific collaboration coming to fruition.”
TAGS
- COVID 19
Last modified: 20 September 2023
Last reviewed: 20 September 2023
